Search
This study compared regional differences in the prevalence of rheumatic heart disease in Indigenous Australian children, and describes the logistical and...
This paper reports on treatment, and preventing infection in close contact, of invasive group A streptococcal (iGAS) using the antibiotic clindamycin and...
Prevalence and antimicrobial resistance of impetigo pathogens in a randomised, controlled trial of impetigo treatment conducted in remote Indigenous communities
Acute rheumatic fever (ARF) is the result of an autoimmune response to pharyngitis caused by infection with group A Streptococcus.
We conducted a systematic review of clinical trials and observational studies that address the utility of SXT for SSTI treatment, caused by either GAS or MRSA
Group A Streptococcus (GAS) or Streptococcus pyogenes is responsible for an estimated 500,000 deaths worldwide each year.
Rheumatic heart disease (RHD) after group A streptococcus (GAS) infections is heritable and prevalent in Indigenous populations. Molecular mimicry between human and GAS proteins triggers proinflammatory cardiac valve-reactive T cells.
The rates of RHD in Timor-Leste are among the highest in the world, and prevalence is higher among girls than boys
The authors present a variety of pressing clinical research questions on optimal RHD prevention and advanced care
The age-standardized disability-adjusted life years rates in the Eastern Mediterranean Region are considerably higher than the global average